ViaCell (VIAC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ViaCell (VIAC)

VIAC 40.77

+3.6%

Dec 4 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: Amy J	1/25/2005 9:59:29 PM
	of 9

ViaCell shares surge after initial offering NEW YORK, Jan 21 (Reuters) - Shares of biotechnology company ViaCell Inc. (VIAC) surged as much as 68 percent in its first day of public trading on Friday after pricing its initial offering at the low end of its expected range. The stock was up $2.31, or 33 percent, at $9.31 on in late morning Nasdaq trade, where it was the top percentage gainer. Earlier it rose as high as $11.75. ViaCell, which is working to develop treatments for a variety of diseases using human cells and stem cell research, priced its IPO at $7 a share before markets opened. Earlier this month, it had put the top end of its estimated price range at $9 a share. Amgen Inc. (AMGN) , the world largest biotechnology company, has a $20 million stake in ViaCell. yahoo.reuters.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext